NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: Sources

Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the second dose and the precaution dose of the vaccines to six months are among the issues likely to be discussed at a meeting of the NTAGI to be held soon. The advisory panel may also review the data of the vaccines for the 5-12 age group.